Skip to main content
PMC home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1973 Sep;66(9):871–873.

Drug treatment of diseases characterized by abnormal movements.

C D Marsden
PMCID: PMC1645440  PMID: 4281483

Full text

PDF
872

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett R. E., Yahr M. D., Duvoisin R. C. Torsion dystonia and spasmodic torticollis--results of treatment with L-dopa. Neurology. 1970 Nov;20(11):107–113. doi: 10.1212/wnl.20.11_part_2.107. [DOI] [PubMed] [Google Scholar]
  2. Carlsson A. Modification of sympathetic function. Pharmacological depletion of catecholamine stores. Pharmacol Rev. 1966 Mar;18(1):541–549. [PubMed] [Google Scholar]
  3. Connell P. H., Corbett J. A., Horne D. J., Mathews A. M. Drug treatment of adolescent tiqueurs. A double-blind trial of Diazepam and Haloperidol. Br J Psychiatry. 1967 Apr;113(497):375–381. doi: 10.1192/bjp.113.497.375. [DOI] [PubMed] [Google Scholar]
  4. Cooper I. S. Levodopa-induced dystonia. Lancet. 1972 Dec 16;2(7790):1317–1318. doi: 10.1016/s0140-6736(72)92694-3. [DOI] [PubMed] [Google Scholar]
  5. Cotzias G. C., Papavasiliou P. S., Fehling C., Kaufman B., Mena I. Similarities between neurologic effects of L-dipa and of apomorphine. N Engl J Med. 1970 Jan 1;282(1):31–33. doi: 10.1056/NEJM197001012820107. [DOI] [PubMed] [Google Scholar]
  6. Dalby M. A. Effect of tetrabenazine on extrapyramidal movement disorders. Br Med J. 1969 May 17;2(5654):422–423. doi: 10.1136/bmj.2.5654.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gilligan B. S., Veale J. L., Wodak J. Propranolol in the treatment of tremor. Med J Aust. 1972 Feb 12;1(7):320–322. doi: 10.5694/j.1326-5377.1972.tb46801.x. [DOI] [PubMed] [Google Scholar]
  8. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev. 1966 Jun;18(2):925–964. [PubMed] [Google Scholar]
  9. KEMPINSKY W. H., BONIFACE W. R., MORGAN P. P., BUSCH A. K. Reserpine in Huntington's chorea. Neurology. 1960 Jan;10:38–42. doi: 10.1212/wnl.10.1.38. [DOI] [PubMed] [Google Scholar]
  10. Klawans H. L., Jr A pharmacologic analysis of Huntington's chorea. Eur Neurol. 1970;4(3):148–163. doi: 10.1159/000114017. [DOI] [PubMed] [Google Scholar]
  11. Marsden C. D., Foley T. H., Owen D. A., McAllister R. G. Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci. 1967 Aug;33(1):53–65. [PubMed] [Google Scholar]
  12. Nybäck H., Sedvall G., Kopin I. J. Accelerated synthesis of dopamine-C14 from tyrosine-C14 in rat brain after chlorpromazine. Life Sci. 1967 Nov 1;6(21):2307–2312. doi: 10.1016/0024-3205(67)90040-9. [DOI] [PubMed] [Google Scholar]
  13. Pakkenberg H. The effect of tetrabenazine in some hyperkinetic syndromes. Acta Neurol Scand. 1968;44(3):391–393. doi: 10.1111/j.1600-0404.1968.tb05581.x. [DOI] [PubMed] [Google Scholar]
  14. RISER M., GAYRAL L., STERN H., TURNIN J., MILLET L. [Treatment of Huntington's chorea with chlorpromazine (largactil) and thioridazine (melleril)]. Rev Otoneuroophtalmol. 1959;31:498–501. [PubMed] [Google Scholar]
  15. Shaw K. M., Hunter K. R., Stern G. M. Medical treatment of spasmodic torticollis. Lancet. 1972 Jun 24;1(7765):1399–1399. doi: 10.1016/s0140-6736(72)91137-3. [DOI] [PubMed] [Google Scholar]
  16. Swash M., Roberts A. H., Zakko H., Heathfield K. W. Treatment of involuntary movement disorders with tetrabenazine. J Neurol Neurosurg Psychiatry. 1972 Apr;35(2):186–191. doi: 10.1136/jnnp.35.2.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. The murmuring heart. Br Med J. 1971 Oct 16;4(5780):125–126. [PMC free article] [PubMed] [Google Scholar]
  18. York D. H. Possible dopaminergic pathway from substantia nigra to putamen. Brain Res. 1970 Jun 3;20(2):233–249. doi: 10.1016/0006-8993(70)90291-x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES